
DALRADA HEALTH ADVISORY BOARD EXPANDS TO SUPPORT BUSINESS GROWTH
Dalrada Corporation (OTCQB: DFCO, “Dalrada”), an innovator in healthcare, green energy, and technology, today announced that the Company completed a second clinical trial on its patent-pending cerVIA™